Zumiez Sales Surge But Its Earnings Outlook is Underwhelming
Teen retailer Zumiez reported solid second quarter results, but the firm failed to provide the Street with strong earnings guidance. We think shares are fairly valued.
Exclusive Analysis for the Discerning Investor
Teen retailer Zumiez reported solid second quarter results, but the firm failed to provide the Street with strong earnings guidance. We think shares are fairly valued.
A video that has been making the rounds challenging the markups at some of the high-end luxury dealers.
A previous version of this article appeared on our website July 21, 2013. Refreshed and updated throughout, as of July 2018. By Brian Nelson, CFA After earning my MBA at the University of Chicago Booth School of Business and training stock and credit analysts from large organizations over the past decade or so, I have heard just about every question (though I admit I am still surprised by many things and remain a very humble student of the markets). I’ve also spent years perfecting the discounted cash flow process for large research organizations such as Morningstar and studied under one of the most famed aggressive growth investors of all time, Richard Driehaus. My knowledge runs the gamut from value through … Read more
Key Takeaways · Valuentum sees four major brand segments o Ultra-Luxury § Richemont, Burberry, LVMH, Gucci (Kering), Chanel, Hermes § Rich heritage brands, economically resilient consumer o Luxury § Marc Jacobs, Tory Burch, Ralph Lauren, Tiffany § Valuable brands, semi-strong barriers to entry o Aspirational § Michael Kors, Marc by Marc Jacobs, Coach, North Face § Popular with younger consumers, strong brand loyalty o Established § Nike, Adidas, Under Armour, lululemon, PVH, Express § Price competitive, exposed to fashion · Our favorite dividend idea: Coach · Fallen Stars: Guess, Bebe · Valuentum’s Take: Brand value is only part of the investment equation Branding has been a powerful force in both marketing and investing for the past century. Companies work hard … Read more
By Valuentum Analysts February 8, 2021 2020 was one for the history books. We covered our thoughts and reflections on the past year in our “2020 Won’t Soon Be Forgotten” article (link here), and now we are looking towards the future. Global health authorities should be able to bring an end to the ongoing coronavirus (‘COVID-19’) pandemic sooner than many had expected as several vaccines have already been improved for emergency use and several others appear increasingly likely to get approved. Global vaccine distribution activities are currently underway, and this should allow the world to slowly return to pre-pandemic activities. Before then, immense stimulus measures launched primarily in developed nations should support global economic activities until the public health crisis … Read more